Rules-Based Medicine (RBM), a Q2 Solutions Company


Rules-Based Medicine (RBM), a Q2 Solutions Company, is the world’s leading multiplexed immunoassay testing laboratory that solves complex drug development challenges with innovative biomarker services and a novel whole blood immunophenotyping device (TruCulture®).  RBM’s internally developed and manufactured immunoassays based on Multi-Analyte Profiling (MAP) and Single-Molecule Array (SimoaTM) ultrasensitive immunoassay technology provides translational and clinical researchers with reproducible and quantitative data for a few or hundreds of human proteins.   The comprehensive menu provides extensive coverage of numerous pathways and delivers accurate pharmacodynamic and safety assessments.  RBM’s CLIA certified biomarker testing laboratory is located in Austin, TX. 

Q2 Solutions is a leading global clinical trial laboratory services organization providing bioanalyticalgenomicsvaccinesflow cytometryanatomic pathologyimmunoassaycompanion diagnostics and central laboratory services with secure, enterprise-wide biospecimen and consent management solutions.  With our industry-leading science, partnership approach and innovative solutions, we’ll make sure our clients get the results that will turn patients’ hope into the help they need.